Dominika T.
- Country
- Poland
- Department
- N/A
Research Overview
- Longterm, openlabel (doseblinded), extension study of eptinezumab in children and adolescents with chronic or episodic migraine
- Efficacy and Safety Evaluation of Intravenous Eptinezumab for Preventive Treatment of Chronic Migraine in Adolescents: A Randomized, Double-Blind, Placebo-Controlled Trial
- Evaluation of NEU-411 Maleate in LRRK2-Driven Early Parkinson's Disease: A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 59 of 95 partner sites.
Specializations
Neurological Disorders
The investigator specializes in studying pediatric migraine disorders, with particular emphasis on developing therapeutic approaches for young patients experiencing episodic migraine.
- Pediatric Migraine Management
- Headache Disorders in Children
- Neurological Pain Conditions
Research activities focus on evaluating innovative treatments for managing migraine frequency in pediatric populations.
Pediatric Medicine
The investigator concentrates on advancing pediatric therapeutic interventions, particularly in the context of neurological conditions affecting young patients.
- Child-Specific Treatment Approaches
- Pediatric Pain Management
- Age-Appropriate Therapies
Clinical interests include developing targeted treatments that address the unique needs of pediatric patients with recurring headache conditions.
Pain Medicine
Expertise extends to the study of pain management solutions specifically designed for young patients experiencing recurring neurological pain conditions.
- Preventive Pain Treatments
- Therapeutic Innovation
- Clinical Outcomes Assessment
The investigator explores therapeutic approaches aimed at reducing the frequency and impact of migraine episodes in children.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.